熱門資訊> 正文
NeuBase Therapeutics宣布收到纳斯达克通知
2024-04-06 04:21
- NeuBase Therapeutics (NASDAQ:NBSE) said on Friday it had received a Nasdaq notice stating that the company was not in compliance with the stock exchange's continued listing requirements.
- Shares of NBSE slipped 2.3% in extended trading.
- According to the Nasdaq notice, NBSE failed to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, in a timely manner.
- The notice has no immediate effect on the listing of the company’s common stock, NBSE added.
- Press Release
More on NeuBase Therapeutics
- Financial information for NeuBase Therapeutics
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
